HIV Treatment and Research: Current Therapies and Future Prospects

Human Immunodeficiency Virus (HIV) infection is not yet curable in the traditional sense, but highly effective treatment exists. The cornerstone of management is antiretroviral therapy (ART), a combination of medications taken daily to suppress viral replication.

How ART Works

  • Reduces plasma viral load to undetectable levels (typically <50 copies/mL).
  • Allows CD4+ T-cell recovery, restoring immune function.
  • Prevents progression to AIDS and reduces transmission risk (Undetectable = Untransmittable, U=U).
  • Enables near-normal life expectancy and quality of life with adherence.

Limitations of Current Therapy

ART does not eliminate HIV from the body. The virus persists in latent reservoirs (e.g., resting memory CD4+ T cells, macrophages, follicular dendritic cells). If treatment stops, viral rebound occurs rapidly. Lifelong adherence is essential.

Research Toward a Cure

  • Functional cure: Sustained viral suppression without ART (post-treatment control). Studied via early ART initiation, immune modulators, therapeutic vaccines.
  • Sterilizing cure: Complete eradication of replication-competent virus. Strategies include "shock and kill" (latency reversal + immune clearance), gene editing (CRISPR/Cas9), and stem cell transplantation (as in the Berlin and London patients).
  • Ongoing clinical trials: Testing broadly neutralizing antibodies, CAR-T cells, and novel latency-reversing agents.

While a cure remains elusive, advances in long-acting injectable ART, pre-exposure prophylaxis (PrEP), and cure research offer hope for ending the HIV epidemic.

HIV & AIDS - Related Articles